• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A Case of Anti-PD-L1-associated Remitting Seronegative Symmetric Synovitis With Pitting Edema.

作者信息

Redman Jason M, Rhea Logan P, Cordes Lisa, Owens Helen, Madan Ravi A, Bilusic Marijo, Gulley James L, Lee Jung-Min, Dahut William L, Karzai Fatima

机构信息

Medical Oncology Service, National Cancer Institute, National Institutes of Health, Bethesda, MD.

Department of Medicine, Inova Fairfax Medical Campus, Falls Church, VA.

出版信息

Clin Genitourin Cancer. 2019 Jun;17(3):e549-e552. doi: 10.1016/j.clgc.2019.02.005. Epub 2019 Feb 14.

DOI:10.1016/j.clgc.2019.02.005
PMID:30850338
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8139240/
Abstract
摘要

相似文献

1
A Case of Anti-PD-L1-associated Remitting Seronegative Symmetric Synovitis With Pitting Edema.一例抗程序性死亡受体配体1相关的缓解性血清阴性对称性滑膜炎伴凹陷性水肿病例。
Clin Genitourin Cancer. 2019 Jun;17(3):e549-e552. doi: 10.1016/j.clgc.2019.02.005. Epub 2019 Feb 14.
2
Nivolumab induced remitting seronegative symmetrical synovitis with pitting edema in a patient with melanoma: a case report.纳武单抗诱发黑色素瘤患者出现缓解性血清阴性对称性滑膜炎伴凹陷性水肿：一例报告
J Med Case Rep. 2018 Feb 26;12(1):48. doi: 10.1186/s13256-018-1579-1.
3
Remitting seronegative symmetrical synovitis with pitting edema (RS3PE) syndrome induced by nivolumab.尼伏单抗诱导的缓解性血清阴性对称性滑膜炎伴凹陷性水肿（RS3PE）综合征。
Semin Arthritis Rheum. 2017 Oct;47(2):281-287. doi: 10.1016/j.semarthrit.2017.03.003. Epub 2017 Mar 8.
4
Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations.度伐利尤单抗联合奥拉帕利治疗伴有和不伴有 DNA 损伤修复突变的转移性去势抵抗性前列腺癌男性患者的疗效。
J Immunother Cancer. 2018 Dec 4;6(1):141. doi: 10.1186/s40425-018-0463-2.
5
Pembrolizumab- and/or pazopanib-induced remitting seronegative symmetrical synovitis with pitting edema in a patient with renal cell carcinoma.帕博利珠单抗和/或帕唑帕尼诱发的肾细胞癌患者缓解性血清阴性对称性滑膜炎伴凹陷性水肿
J Oncol Pharm Pract. 2020 Jul;26(5):1230-1233. doi: 10.1177/1078155219884113. Epub 2019 Nov 17.
6
Development of Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome with Pembrolizumab for Lung Squamous Cell Carcinoma.帕博利珠单抗治疗肺鳞癌致缓解性血清阴性对称性滑膜炎伴凹陷性水肿综合征。
Intern Med. 2024 Jul 15;63(14):2089-2096. doi: 10.2169/internalmedicine.2475-23. Epub 2023 Dec 11.
7
Remitting seronegative symmetrical synovitis with pitting edema: a review.缓解性血清阴性对称性滑膜炎伴凹陷性水肿：综述。
J Investig Med. 2021 Jan;69(1):86-90. doi: 10.1136/jim-2020-001613. Epub 2020 Oct 29.
8
Remitting Seronegative Symmetric Synovitis With Pitting Edema Associated With Partial Melanoma Response Under Anti-CTLA-4 and Anti-Programmed Death 1 Combination Treatment.
Arthritis Rheumatol. 2018 Aug;70(8):1358. doi: 10.1002/art.40506. Epub 2018 Jul 7.
9
Idiopathic remitting seronegative symmetrical synovitis with pitting edema syndrome associated with bilateral pleural and pericardial effusions: a case report.伴有双侧胸腔和心包积液的特发性缓解性血清阴性对称性滑膜炎伴凹陷性水肿综合征：一例报告
J Med Case Rep. 2016 Jul 20;10:198. doi: 10.1186/s13256-016-0983-7.
10
Remitting seronegative symmetrical synovitis with pitting edema syndrome with two different underlying malignancies: A case report.伴有凹陷性水肿综合征的缓解性血清阴性对称性滑膜炎合并两种不同潜在恶性肿瘤：病例报告
Medicine (Baltimore). 2025 Apr 4;104(14):e42091. doi: 10.1097/MD.0000000000042091.

引用本文的文献

1
Development of Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome with Pembrolizumab for Lung Squamous Cell Carcinoma.帕博利珠单抗治疗肺鳞癌致缓解性血清阴性对称性滑膜炎伴凹陷性水肿综合征。
Intern Med. 2024 Jul 15;63(14):2089-2096. doi: 10.2169/internalmedicine.2475-23. Epub 2023 Dec 11.
2
Remitting seronegative symmetrical synovitis with pitting edema syndrome induced by pembrolizumab in patient with urothelial carcinoma.帕博利珠单抗诱发的尿路上皮癌患者的缓解性血清阴性对称性滑膜炎伴凹陷性水肿综合征
IJU Case Rep. 2022 May 3;5(4):219-222. doi: 10.1002/iju5.12426. eCollection 2022 Jul.
3
RS3PE Following Treatment With Combination of Hormonal Therapies Plus Ipilimumab in a Patient With Metastatic Prostate Cancer.转移性前列腺癌患者接受激素疗法联合伊匹木单抗治疗后出现缓解的血清阴性对称性滑膜炎伴凹陷性水肿（RS3PE）
J Immunother Precis Oncol. 2020 May 14;3(3):128-132. doi: 10.36401/JIPO-20-2. eCollection 2020 Aug.

本文引用的文献

1
Activity of durvalumab plus olaparib in metastatic castration-resistant prostate cancer in men with and without DNA damage repair mutations.度伐利尤单抗联合奥拉帕利治疗伴有和不伴有 DNA 损伤修复突变的转移性去势抵抗性前列腺癌男性患者的疗效。
J Immunother Cancer. 2018 Dec 4;6(1):141. doi: 10.1186/s40425-018-0463-2.
2
Long-term efficacy, tolerability and overall survival in patients with platinum-sensitive, recurrent high-grade serous ovarian cancer treated with maintenance olaparib capsules following response to chemotherapy.接受化疗缓解后的铂类敏感型复发性高级别浆液性卵巢癌患者使用奥拉帕利胶囊维持治疗的长期疗效、耐受性和总生存期。
Br J Cancer. 2018 Oct;119(9):1075-1085. doi: 10.1038/s41416-018-0271-y. Epub 2018 Oct 24.
3
Pembrolizumab for advanced prostate adenocarcinoma: findings of the KEYNOTE-028 study.帕博利珠单抗治疗晚期前列腺腺癌：KEYNOTE-028 研究结果。
Ann Oncol. 2018 Aug 1;29(8):1807-1813. doi: 10.1093/annonc/mdy232.
4
Serum matrix metalloproteinase 3 in detecting remitting seronegative symmetrical synovitis with pitting edema syndrome: A case report.血清基质金属蛋白酶3在检测缓解型血清阴性对称性滑膜炎伴凹陷性水肿综合征中的应用：一例报告
World J Clin Cases. 2018 May 16;6(5):84-87. doi: 10.12998/wjcc.v6.i5.84.
5
Nivolumab induced remitting seronegative symmetrical synovitis with pitting edema in a patient with melanoma: a case report.纳武单抗诱发黑色素瘤患者出现缓解性血清阴性对称性滑膜炎伴凹陷性水肿：一例报告
J Med Case Rep. 2018 Feb 26;12(1):48. doi: 10.1186/s13256-018-1579-1.
6
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline.免疫检查点抑制剂治疗患者免疫相关不良反应的管理：美国临床肿瘤学会临床实践指南。
J Clin Oncol. 2018 Jun 10;36(17):1714-1768. doi: 10.1200/JCO.2017.77.6385. Epub 2018 Feb 14.
7
A Case of Paraneoplastic Remitting Seronegative Symmetrical Synovitis with Pitting Edema Syndrome Improved by Chemotherapy.1例化疗改善的副肿瘤性缓解血清阴性对称性滑膜炎伴凹陷性水肿综合征病例
Case Rep Oncol. 2017 Dec 20;10(3):1131-1137. doi: 10.1159/000484977. eCollection 2017 Sep-Dec.
8
Resolution of remitting seronegative symmetrical synovitis with pitting edema (RS3PE) during Nivolumab therapy for non-small cell lung cancer: a case report.纳武单抗治疗非小细胞肺癌期间缓解性血清阴性对称性滑膜炎伴凹陷性水肿（RS3PE）的病例报告
Semin Arthritis Rheum. 2018 Oct;48(2):e17-e20. doi: 10.1016/j.semarthrit.2017.12.013. Epub 2018 Jan 6.
9
Olaparib tablets as maintenance therapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT-Ov21): a double-blind, randomised, placebo-controlled, phase 3 trial.奥拉帕利片作为 BRCA1/2 突变的铂敏感复发性卵巢癌患者的维持治疗（SOLO2/ENGOT-Ov21）：一项双盲、随机、安慰剂对照、III 期临床试验。
Lancet Oncol. 2017 Sep;18(9):1274-1284. doi: 10.1016/S1470-2045(17)30469-2. Epub 2017 Jul 25.
10
Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation.奥拉帕利治疗携种系 BRCA 突变的转移性乳腺癌患者。
N Engl J Med. 2017 Aug 10;377(6):523-533. doi: 10.1056/NEJMoa1706450. Epub 2017 Jun 4.